Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5139]

Addition of trastuzumab to chemo does not provide significant survival benefit...

Dr Anna Dorothea Wagner - Lausanne University Hospital, Lausanne, Switzerland

Addition of trastuzumab to chemo does not provide significant survival benefit in HER-2 positive stomach cancer ( Dr Anna Dorothea Wagner - Lausanne University Hospital, Lausanne, Switzerland )

UGN-102 shows better results after 12 months of treatment for low-grade...

Dr Sandip Prasad - Garden State Urology, Morristown, USA

UGN-102 shows better results after 12 months of treatment for low-grade intermediate-risk NMIBC ( Dr Sandip Prasad - Garden State Urology, Morristown, USA )

177Lu-PSMA-617 with concomitant ARPIs shows is more efficacious than SoC in...

Dr Omid Yazdanpanah - University of California Irvine, Irvine, USA

177Lu-PSMA-617 with concomitant ARPIs shows is more efficacious than SoC in mCRPC ( Dr Omid Yazdanpanah - University of California Irvine, Irvine, USA )

CaboNivo shows sustained long-term benefits for survival and tumour progression...

Prof Camillo Porta - University of Bari, Bari, Italy,

CaboNivo shows sustained long-term benefits for survival and tumour progression as a 1L treatment of aRCC ( Prof Camillo Porta - University of Bari, Bari, Italy, )

HSD3B1 inheritance reduces OS in high-risk nmPC patients on ADT enzalutamide...

Dr Nima Sharifi - University of Miami Miller School of Medicine, Miami, USA

HSD3B1 inheritance reduces OS in high-risk nmPC patients on ADT enzalutamide, abiraterone acetate plus prednisolone ( Dr Nima Sharifi - University of Miami Miller School of Medicine, Miami, USA )

Enfortumab vedotin in combination with pembrolizumab shows improved survival...

Prof Thomas Powles - Barts Cancer Institute, London, England

Enfortumab vedotin in combination with pembrolizumab shows improved survival rates in la/mUC ( Prof Thomas Powles - Barts Cancer Institute, London, England )

ASCO GU 2025: Latest updates in mRCC

Dr Bradley McGregor, Dr Stephanie Berg, Prof Viktor Grünwald and Prof Roberto...

ASCO GU 2025: Latest updates in mRCC ( Dr Bradley McGregor, Dr Stephanie Berg, Prof Viktor Grünwald and Prof Roberto Iacovelli )

Ageing and cancer: Inflammation promotes ageing-associated oncogenesis in the...

Dr James DeGregori - University of Colorado School of Medicine, Aurora, Colorado

Ageing and cancer: Inflammation promotes ageing-associated oncogenesis in the lung ( Dr James DeGregori - University of Colorado School of Medicine, Aurora, Colorado )

Low-dose aspirin can reduce recurrence rates in colorectal cancer patients with...

Prof Anna Martling - Karolinska Institutet, Stockholm, Sweden

Low-dose aspirin can reduce recurrence rates in colorectal cancer patients with PI3K pathway alterations ( Prof Anna Martling - Karolinska Institutet, Stockholm, Sweden )

Nivolumab plus ipilimumab shows superior efficacy in metastatic colorectal...

Dr Thierry Andre - Sorbonne Université and Saint Antoine Hospital, Paris, France

Nivolumab plus ipilimumab shows superior efficacy in metastatic colorectal compared to nivolumab monotherapy ( Dr Thierry Andre - Sorbonne Université and Saint Antoine Hospital, Paris, France )

Assessment and management of toxic effects of cancer therapy in elderly...

Dr Houda Belfekih - Mohamed Taher Maamouri Hospital, Nabeul, Tunisia

Assessment and management of toxic effects of cancer therapy in elderly patients in Tunisia ( Dr Houda Belfekih - Mohamed Taher Maamouri Hospital, Nabeul, Tunisia )

The use of IORT at Merit Health Surgical Oncology

Dr Phillip Ley - Merit Health Surgical Oncology, Flowood, USA

The use of IORT at Merit Health Surgical Oncology ( Dr Phillip Ley - Merit Health Surgical Oncology, Flowood, USA )

More from ecancer